Assistant professorDepartment of Pediatrics, Nara Medical UniversityKashihara, Nara, Japan
PB0690 - Factor X consumption could cause attenuation of emicizumab effect; A case report of severe hemophilia A with inhibitor treated by emicizumab and factor VIII-bypassing agents
Monday, June 26, 202318:30 – 19:30 ET
PB0847 - DDAVP-trial has a possible role for auxiliary diagnosis in type 1 and type 2 von Willebrand disease.
